Remove 2001 Remove Families Remove Family Remove Screening
article thumbnail

AMPLIFY™ Technology Enhances Prenatal Screening for 22q11.2 Microdeletion

Myriad Genetics

Less invasive options like prenatal cell-free DNA (cfDNA) screens can also be used to help identify the microdeletion. According to a study in Genes (Basel) , cfDNA screens have “a 70–83% detection rate and a 40–50% positive predictive value (PPV) for most associated 22q microdeletions.” We observed 100% PPV. DiGeorge syndrome (22q11.2

article thumbnail

Breast Cancer Incidence Trends Vary by Age

Physician's Weekly

million women diagnosed with breast cancer from 2001 through 2019. “The findings of this study suggest that breast cancer incidence trends among older women should be disaggregated by age groups to account for age-related differences in screening and other risk factors,” the authors write. Lee Argov, M.P.H.,